tirzepatide dementia Revealed: How Popular Weight Loss Drug May Lower and Stroke Risk Could your diabetes medication protect

None of these platforms is risk-free the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, and GLP-1 medications carry well-documented GI side effects (nausea, vomiting, diarrhea, constipation) plus less-common documented events including pancreatitis, gallbladder disease, and acute kidney injury

By weeks 58, the body develops tolerance to many of the unpleasant sensations, and nausea frequency drops significantly in 6070% of patients

Others require BMI 32 or higher

Dehydration is particularly dangerous and may lead to weakness, confusion, or even hospitalization

In conclusion, Semaglutide has demonstrated significant efficacy in weight loss, but its numerous side effects and risks cannot be ignored